Skip to content
Advertisement

FILE -In this Monday, Sept. 3, 2019 file photo, the logo is pictured of the pharmaceutical giant Servier Laboratoires in Suresnes, outside Paris. French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines after a massive trial around a diabetes drug used as a diet pill. The popular drug, called Mediator, became one of France’s biggest modern health scandals. The trial is wrapping up Monday, July 6, 2020 after more than six months of exceptional proceedings targeting Servier and France’s medicines watchdog. (AP Photo/Michel Euler, File)

FILE -In this Monday, Sept. 3, 2019 file photo, the logo is pictured of the pharmaceutical giant Servier Laboratoires in Suresnes, outside Paris. French pharmaceutical company Servier Laboratories is facing millions of euros in potential fines after a massive trial around a diabetes drug used as a diet pill. The popular drug, called Mediator, became one of France’s biggest modern health scandals. The trial is wrapping up Monday, July 6, 2020 after more than six months of exceptional proceedings targeting Servier and France’s medicines watchdog. (AP Photo/Michel Euler, File)

Featured Photo Galleries